Jafron Biomedical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
298,325.10
364,580.40
499,825.10
533,278.10
703,941.90
997,622.80
Cost of Goods Sold (COGS) incl. D&A
50,533.80
59,079.80
82,915.10
93,674.60
120,473.70
164,391.40
Gross Income
247,791.30
305,500.60
416,910.00
439,603.60
583,468.20
833,231.30
SG&A Expense
107,192.20
136,357.90
189,884.60
211,063.70
296,915.50
424,099.40
EBIT
140,161.70
169,092.80
226,918.00
230,534.30
286,726.70
409,082.30
Non Operating Income/Expense
6,811.80
17,071.10
7,782.50
1,074.90
46,337.50
20,319.70
Interest Expense
-
-
-
64.90
93.00
140.60
Pretax Income
151,911.20
191,114.60
239,822.80
241,459.30
340,137.70
473,136.90
Income Tax
25,126.70
31,066.40
39,381.80
39,340.80
55,685.80
72,191.50
Consolidated Net Income
126,784.60
160,048.20
200,441.00
202,118.50
284,451.90
400,945.50
Net Income
126,784.60
160,048.20
200,441.00
202,118.50
284,414.00
401,980
Net Income After Extraordinaries
126,784.60
160,048.20
200,441.00
202,118.50
284,414.00
401,980
Net Income Available to Common
126,784.60
160,048.20
200,441.00
202,118.50
284,414.00
401,980
EPS (Basic)
3.08
3.88
4.87
0.52
0.68
0.96
Basic Shares Outstanding
41,200.00
41,200.00
41,200.00
388,689.40
415,683.20
417,276.40
EPS (Diluted)
3.08
3.88
4.87
0.52
0.68
0.96
Diluted Shares Outstanding
41,200.00
41,200.00
41,200.00
388,689.40
415,683.20
417,276.40
EBITDA
143,256.70
173,506.80
236,694.10
247,349.70
303,131.70
431,258.30
Other Operating Expense
437.40
49.90
107.40
1,994.40
174.10
49.60
Non-Operating Interest Income
4,937.70
4,950.70
5,122.30
8,051.00
7,166.50
44,099.30
Minority Interest Expense
-
-
-
-
37.90
1,034.50

About Jafron Biomedical Co.

View Profile
Address
98 Keji 6th Road
Zhuhai Guangdong 519085
China
Employees -
Website http://www.jafron.com
Updated 07/08/2019
Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include single-use blood perfusion devices, blood perfusion machines, disposable plasma bilirubin adsorbers, and DX-10 blood purification machines. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China.